Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
469 - Dear PAAB. Is it acceptable in branded APS to illustrate the patient journey using data from authoritative sources? For example, the patient has suffered for years and has tried a number of treatments before seeking medical advice. Thank you.
-
It is difficult to set up case studies in patient information as these tend to be inherently promotional (thus contravening PAAB s6). The PAAB website document “Guidance on Branded Patient Information” does discuss the matter of case studies. I urge you to read the case study segment and sections 1 & 2 before committing to your project. The patient information provisions were intended to enable manufacturers to create tools informing the patient about how to get the most out of the product they are taking and to inform them about their medical condition. It is not acceptable to discuss the failings of other medications.
